Curis, Inc.Long
Great partners, well oversold, FDA approved, small float, lots o
This is worth owning at $1.33. Great partners in Roche and Genentech, lots of cash (55M), small float, and small debt. Bleed rate is also very small. Great potential here with this falling wedge pattern...
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.